Search research articles
Contact Us
Filters
Showing results (71-80 of 101) with videos related to
Page
of 11
Sort By:
Immunology Letters
|
May 1, 1995
Phosphatidylinositol metabolism in lymphocytes of chronic alcoholic patients after anti-CD3 stimulation
S Hrelia, M Celadon, A Bordoni, et al.
Biochemical and Biophysical Research Communications
|
November 2, 1995
Essential fatty acid metabolism in cultured rat cardiomyocytes in response to either N-6 or N-3 fatty acid supplementation
S Hrelia, J A Lopez Jimenez, A Bordoni, et al.
Journal of Neurology
|
July 1, 1994
Multiple sclerosis and mitochondrial myopathy: an unusual combination of diseases
L Bet, M Moggio, G P Comi, et al.
Acta Neuropathologica
|
January 1, 1994
Mitochondrial myopathy: correlation between oxidative defect and mitochondrial DNA deletions at single fiber level
A Prelle, G Fagiolari, N Checcarelli, et al.
British Journal of Cancer
|
March 19, 2009
Differing deregulation of EGFR and downstream proteins in primary colorectal cancer and related metastatic sites may be clinically relevant
F Molinari, V Martin, P Saletti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 12, 2005
Variation in survival after diagnosis of breast cancer in Switzerland
T Fisch, P Pury, N Probst, et al.
Brain : a Journal of Neurology
|
February 1, 1994
Clinical variability in Becker muscular dystrophy. Genetic, biochemical and immunohistochemical correlates
G P Comi, A Prelle, N Bresolin, et al.
Alcoholism, Clinical and Experimental Research
|
October 1, 1993
In vivo effect of chronic ethanol consumption on the fatty acid composition of phosphatidylinositols in resting and anti-CD3-activated lymphocytes
S Hrelia, P L Biagi, A Bordoni, et al.
Journal of Registry Management
|
June 4, 2014
Economic evaluation of cancer registration in Europe
R Zanetti, L Sacchetto, M Calvia, et al.
In Vivo (Athens, Greece)
|
June 21, 2002
A phase II study of chemoneuroimmunotherapy with platinum, subcutaneous low-dose interleukin-2 and the pineal neurohormone melatonin (P.I.M.) as a second-line therapy in metastatic melanoma patients progressing on dacarbazine plus interferon-alpha
P Lissoni, M Vaghi, A Ardizzoia, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 101) with videos related to
Sort By:
Page
of 11
Immunology Letters
|
May 1, 1995
Phosphatidylinositol metabolism in lymphocytes of chronic alcoholic patients after anti-CD3 stimulation
S Hrelia, M Celadon, A Bordoni, et al.
Biochemical and Biophysical Research Communications
|
November 2, 1995
Essential fatty acid metabolism in cultured rat cardiomyocytes in response to either N-6 or N-3 fatty acid supplementation
S Hrelia, J A Lopez Jimenez, A Bordoni, et al.
Journal of Neurology
|
July 1, 1994
Multiple sclerosis and mitochondrial myopathy: an unusual combination of diseases
L Bet, M Moggio, G P Comi, et al.
Acta Neuropathologica
|
January 1, 1994
Mitochondrial myopathy: correlation between oxidative defect and mitochondrial DNA deletions at single fiber level
A Prelle, G Fagiolari, N Checcarelli, et al.
British Journal of Cancer
|
March 19, 2009
Differing deregulation of EGFR and downstream proteins in primary colorectal cancer and related metastatic sites may be clinically relevant
F Molinari, V Martin, P Saletti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 12, 2005
Variation in survival after diagnosis of breast cancer in Switzerland
T Fisch, P Pury, N Probst, et al.
Brain : a Journal of Neurology
|
February 1, 1994
Clinical variability in Becker muscular dystrophy. Genetic, biochemical and immunohistochemical correlates
G P Comi, A Prelle, N Bresolin, et al.
Alcoholism, Clinical and Experimental Research
|
October 1, 1993
In vivo effect of chronic ethanol consumption on the fatty acid composition of phosphatidylinositols in resting and anti-CD3-activated lymphocytes
S Hrelia, P L Biagi, A Bordoni, et al.
Journal of Registry Management
|
June 4, 2014
Economic evaluation of cancer registration in Europe
R Zanetti, L Sacchetto, M Calvia, et al.
In Vivo (Athens, Greece)
|
June 21, 2002
A phase II study of chemoneuroimmunotherapy with platinum, subcutaneous low-dose interleukin-2 and the pineal neurohormone melatonin (P.I.M.) as a second-line therapy in metastatic melanoma patients progressing on dacarbazine plus interferon-alpha
P Lissoni, M Vaghi, A Ardizzoia, et al.
Page
of 11